<DOC>
	<DOCNO>NCT01104753</DOCNO>
	<brief_summary>Confirmation safety profile Pentasa slow release tablet 500 mg patient ulcerative colitis ( UC ) .</brief_summary>
	<brief_title>A Study Pentasa Patients With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Patients suffer ulcerative colitis Hypersensitivity mesalazine , salicylates excipient Severe damage liver renal function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>